• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Enhabit Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    2/25/25 4:21:43 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care
    Get the next $EHAB alert in real time by email
    ehab-20250225
    false000180373700018037372025-02-252025-02-25

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (date of earliest event reported): February 25, 2025
    Enhabit, Inc.
    (Exact name of registrant as specified in its charter)

    Delaware001-4140647-2409192
    (State or other jurisdiction (Commission(IRS Employer
    of incorporation) File Number) Identification No.)

    6688 N. Central Expressway, Suite 1300, Dallas, Texas 75206
    (Address of principal executive offices, including zip code)
    (214) 239-6500
    (Registrant’s telephone number, including area code)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, par value $0.01 per shareEHABNew York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
        Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





    Item 7.01. Regulation FD Disclosure.*
    The Board of Directors of Enhabit, Inc. (the “Company”) announced its intention to nominate Stephan Rodgers to stand for election as a director of the Company at its 2025 annual meeting of stockholders. A copy of the press release issued by the Company on February 25, 2025, is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
    Item 9.01. Financial Statements and Exhibits.
    (d)    Exhibits.
    Exhibit Number
    Description
    99.1
    Press release dated February 25, 2025 (furnished herewith).*
    104Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document

    * The information in Item 7.01, including Exhibit 99.1, is being “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be incorporated into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, unless specifically identified as being incorporated therein by reference.



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
    ENHABIT, INC.
    By:/s/ Dylan C. Black
    Name:Dylan C. Black
    Title:General Counsel
    Dated: February 25, 2025

    Get the next $EHAB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EHAB

    DatePrice TargetRatingAnalyst
    12/9/2024$8.25 → $9.50Hold → Buy
    Jefferies
    5/14/2024$8.50Underperform → Market Perform
    Leerink Partners
    5/9/2024$14.00 → $8.75Buy → Hold
    Jefferies
    3/7/2024$9.50Sell → Neutral
    UBS
    12/12/2023$12.00Market Perform
    TD Cowen
    6/20/2023$10.00Underperform
    SVB Securities
    3/16/2023$15.00Neutral
    Goldman
    12/13/2022$18.00Market Perform
    CJS Securities
    More analyst ratings

    $EHAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Enhabit Inc. upgraded by Jefferies with a new price target

      Jefferies upgraded Enhabit Inc. from Hold to Buy and set a new price target of $9.50 from $8.25 previously

      12/9/24 7:37:08 AM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Enhabit Inc. upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded Enhabit Inc. from Underperform to Market Perform and set a new price target of $8.50

      5/14/24 7:59:14 AM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Enhabit Inc. downgraded by Jefferies with a new price target

      Jefferies downgraded Enhabit Inc. from Buy to Hold and set a new price target of $8.75 from $14.00 previously

      5/9/24 6:24:32 AM ET
      $EHAB
      Medical/Nursing Services
      Health Care